Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

Ionis Pharmaceuticals, Inc. today announced that it has entered into a license agreement under which Sobi® receives exclusive rights in countries outside the U.S., Canada and China to commercialize ...

Welcome to the Fourth Quarter 2024 Aquestive Therapeutics Earnings Conference ... the team will be joined by Dr. Carl Kraus, Chief Medical Officer; Dr. Stephen Wargacki, Chief Science Officer ...

I would now like to turn the call over to Alina Venezia, Director of Investor Relations for Esperion Therapeutics ... Consequently, to further aid healthcare professionals in the management ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts said.

A team from the US Centers for Disease Control and Prevention arrived in Texas this week to aid in the response ... on the ground” and learn about therapeutics “ignored” by the agency.

You might think you don’t need a hearing aid, and you might be right. But in general, hearing loss eventually comes to all of ...

Hearing loss is far more common than many people realize, affecting millions across all age groups. While it’s often ...

Hearing loss can seriously affect your everyday life, crippling conversations and overall quality of life. Regular hearing aids can require expensive consultations, medical examinations, and ...